908 related articles for article (PubMed ID: 18363755)
1. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.
Fujimura T; Okuyama R; Ito Y; Aiba S
Br J Dermatol; 2008 Jun; 158(6):1256-63. PubMed ID: 18363755
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses.
de Boer OJ; van der Loos CM; Teeling P; van der Wal AC; Teunissen MB
J Histochem Cytochem; 2007 Sep; 55(9):891-8. PubMed ID: 17478450
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion.
Szegedi A; Baráth S; Nagy G; Szodoray P; Gál M; Sipka S; Bagdi E; Banham AH; Krenács L
Br J Dermatol; 2009 May; 160(5):984-93. PubMed ID: 19222459
[TBL] [Abstract][Full Text] [Related]
4. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis.
Bovenschen HJ; van Vlijmen-Willems IM; van de Kerkhof PC; van Erp PE
Dermatology; 2006; 213(2):111-7. PubMed ID: 16902287
[TBL] [Abstract][Full Text] [Related]
5. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
6. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
7. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
8. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
9. Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in psoriasis vulgaris.
Chen L; Shen Z; Wang G; Fan P; Liu Y
J Dermatol Sci; 2008 Sep; 51(3):200-3. PubMed ID: 18562180
[No Abstract] [Full Text] [Related]
10. Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis.
Ito Y; Adachi Y; Makino T; Higashiyama H; Fuchizawa T; Shimizu T; Miyawaki T
Ann Allergy Asthma Immunol; 2009 Aug; 103(2):160-5. PubMed ID: 19739430
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions.
Okui T; Ito H; Honda T; Amanuma R; Yoshie H; Yamazaki K
Oral Microbiol Immunol; 2008 Feb; 23(1):49-54. PubMed ID: 18173798
[TBL] [Abstract][Full Text] [Related]
12. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.
Franz B; Fritzsching B; Riehl A; Oberle N; Klemke CD; Sykora J; Quick S; Stumpf C; Hartmann M; Enk A; Ruzicka T; Krammer PH; Suri-Payer E; Kuhn A
Arthritis Rheum; 2007 Jun; 56(6):1910-20. PubMed ID: 17530636
[TBL] [Abstract][Full Text] [Related]
13. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
14. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
16. Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides.
Ortonne N; Buyukbabani N; Delfau-Larue MH; Bagot M; Wechsler J
Mod Pathol; 2003 Sep; 16(9):857-62. PubMed ID: 13679448
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
[TBL] [Abstract][Full Text] [Related]
20. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.
Mor A; Luboshits G; Planer D; Keren G; George J
Eur Heart J; 2006 Nov; 27(21):2530-7. PubMed ID: 16954132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
